HeimP8A • SGX
add
Cordlife Group Ltd
Við síðustu lokun
0,16 $
Árabil
0,12 $ - 0,46 $
Markaðsvirði
41,47 m. SGD
Meðalmagn
24,84 þ.
V/H-hlutf.
-
A/V-hlutfall
-
Aðalkauphöll
SGX
Viðskiptafréttir
CNBC
fyrir 7 klukkustundum
Stock futures are flat Sunday ahead of shortened trading week: Live updates
0,97%
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (SGD) | jún. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 4,60 m. | -67,54% |
Rekstrarkostnaður | 8,59 m. | -6,80% |
Nettótekjur | -6,18 m. | -655,33% |
Hagnaðarhlutfall | -134,45 | -1.810,56% |
Hagnaður á hvern hlut | — | — |
EBITDA | -6,84 m. | -615,37% |
Virkt skatthlutfall | 8,73% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (SGD) | jún. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 59,54 m. | -15,89% |
Heildareignir | 224,31 m. | -4,16% |
Heildarskuldir | 101,27 m. | 3,31% |
Eigið fé alls | 123,03 m. | — |
Útistandandi hlutabréf | 256,31 m. | — |
Eiginfjárgengi | 0,32 | — |
Arðsemi eigna | -8,79% | — |
Ávöxtun eigin fjár | -15,66% | — |
Peningaflæði
Breyting á handbæru fé
| (SGD) | jún. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | -6,18 m. | -655,33% |
Handbært fé frá rekstri | -2,95 m. | -192,71% |
Reiðufé frá fjárfestingum | 2,90 m. | 258,76% |
Reiðufé frá fjármögnun | -549,50 þ. | -19,59% |
Breyting á handbæru fé | -498,00 þ. | -153,06% |
Frjálst peningaflæði | -4,65 m. | -1.473,26% |
Um
Incorporated in May 2001, Cordlife Group Limited, is a consumer health company and one of the leading providers of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
The Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six key markets namely Singapore, Hong Kong, India, Indonesia and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers a comprehensive suite of diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
In January 2018, Cordlife acquired HealthBaby Biotech Co., Limited, the largest private cord blood bank in Hong Kong. Through its majority-owned subsidiary, Stemlife Berhad in Malaysia, Cordlife controls an indirect stake in Thailand's largest private cord blood bank, Thai Stemlife. Cordlife is also the first Singapore private cord blood bank to provide cord blood and cord lining banking services in Myanmar and Vietnam. Wikipedia
Framkvæmdastjóri
Stofnsett
2. maí 2001
Vefsvæði
Starfsfólk
111
